Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
The Badminton Association of India (BAI) has announced a 14-member-strong India squad for
- Men’s Sr Hockey Nationals to be played in division-based format from April 4
- Mensik denies Djokovic 100th title in Miami final
- KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics
- Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award
- Djokovic, Alcaraz land in same half of Miami draw
New study show immunity drops quickly in mild COVID-19 cases Last Updated : 22 Jul 2020 08:31:16 AM IST COVID-19 antibodies A study shows that in people with mild COVID-19 cases, their antibodies against the coronavirus drop sharply over the first three months after infection.
A research team at the University of California, Los Angeles, did an in-depth study of 34 people who had recovered from mild COVID-19 infections. They tested their blood two or three times over three months, Xinhua news agency reported on Tuesday.The researchers found a rapid drop in antibodies - the immune system proteins that help stop viruses from infecting cells in the body. On average, the antibody levels fell by half every 73 days, according to the study published in The New England Journal of Medicine.The findings raise concern that humoral immunity against SARS-CoV-2 may not be long lasting in persons with mild illness, who compose the majority of persons with COVID-19, said the study.Further studies will be needed to define a quantitative protection threshold and rate of decline of antiviral antibodies beyond 90 days, according to the study.IANS Washington For Latest Updates Please-
Join us on
Follow us on
172.31.16.186